Angelo J. Trapani

Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial

John R. Teerlink, Gad Cotter, Beth A. Davison et al. · The Lancet · 2012 · 896 citations

Heart Failure, Cardiac Anaesthesia, Cardiogenic Shock +10

Effect of Serelaxin on Cardiac, Renal, and Hepatic Biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) Development Program

Marco Metra, Gad Cotter, Beth A. Davison et al. · Journal of the American College of Cardiology · 2012 · 423 citations · Full text

Heart Failure, Stress, Medicine +10

Effects of a Novel Aldosterone Synthase Inhibitor for Treatment of Primary Hypertension

David A. Calhoun, William B. White, Henry Krum et al. · Circulation · 2011 · 206 citations

Potent and Selective Non-Peptidic Inhibitors of Endothelin-Converting Enzyme-1 with Sustained Duration of Action

Stéphane De Lombaert, Louis Blanchard, Lisa B. Stamford et al. · Journal of Medicinal Chemistry · 2000 · 100 citations · Full text

Cgs 35066, Selective Non-peptidic Inhibitors, Pharmacotherapy +17

Dicarboxylic Acid Dipeptide Neutral Endopeptidase Inhibitors

Gary M. Ksander, Raj D. Ghai, Reynalda deJesus et al. · Journal of Medicinal Chemistry · 1995 · 81 citations · Full text

Inhibitory Activity, Medicinal Chemistry, Plasma Inhibitory Activity +14